Skip to content

Clinical study on the treatment of diabetic nephropathy by Tangshenkang capsule

Clinical study on the treatment of diabetic nephropathy by Tangshenkang capsule

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013758
Enrollment
Unknown
Registered
2017-12-07
Start date
2017-12-11
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

observation group:Tangshenkang capsule

Sponsors

Gansu Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: The diagnosis standard of type 2 diabetes and diabetic nephropathy in III or IV period;And TCM syndrome:deficiency of both Qi and Yin, deficiency of kidney Qi, turbid?stasis obstructing collaterals. Aged 30 to 75 years; Volunteer subject, and signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Exclusion of the following facts which non-diabetic nephropathy increase urinary trace albumin, such as primary hypertension, heart failure or other renal disease; 2. There is a serious heart disease, or a combination of other serious primary diseases, mental illness; 3. There are acute complications of diabetes and severe infection; 4. Pregnant,prepare a pregnancy or lactating women 5. Blood lipid levels are three times higher than normal; 6. Patients who are participating in other drug clinical studies.

Design outcomes

Primary

MeasureTime frame
Neutrophil-to-lymphocyte ratio;24 hours total urine protein;The urinary ratio of albumin to creatinin;C-reactive protein;Cystatin c;Estimated glomerular filtration rate (eGRF);The homeostasis model assessment of insulin resistance(HOMA-IR);

Secondary

MeasureTime frame
Fasting plasma glucose;Fasting serum insulin;

Countries

China

Contacts

Public ContactZhang Dinghua

Gansu Provincial Hospital of TCM

zhangdinghua2010@sina.com+86 15002591560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026